Relationship between dietary inflammatory index and metabolic dysfunction associated steatotic liver disease in children

Relationship between dietary inflammatory index and metabolic dysfunction associated steatotic liver disease in children

Abstract Emerging research suggests a connection between dietary habits and metabolic dysfunction associated steatotic liver disease (MASLD). We aimed to assess the relationship between the Dietary Inflammatory Index (DII) and the severity of MASLD. This cross-sectional study involved 125 participan...

Full description

Saved in:
Bibliographic Details
Main Authors: Fateme Amiri, Jalal Moludi, Touraj Ahmadi Jouybari, Mahmoud Ghasemi, Maryam Sharifi, Behzad Mahaki, Davood Soleimani
Format: Article
Language:English
Published: Nature Portfolio 2025-02-01
Series:Scientific Reports
Subjects:
Non-alcoholic fatty liver disease
Fibrosis
Diet
Inflammation
Pediatrics
Online Access:https://doi.org/10.1038/s41598-025-89690-x
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Emerging research suggests a connection between dietary habits and metabolic dysfunction associated steatotic liver disease (MASLD). We aimed to assess the relationship between the Dietary Inflammatory Index (DII) and the severity of MASLD. This cross-sectional study involved 125 participants aged 7–18 with MASLD. Dietary intakes were assessed using a validated 147-item food frequency questionnaire. The DII was applied to measure diet-induced inflammation, categorizing diets into anti-inflammatory (DII < -1) and inflammatory diets (DII > + 1). To evaluate hepatic steatosis and fibrosis, transabdominal ultrasonography and the fibrosis-4 (FIB-4) index were utilized. After adjusting for potential confounding factors, individuals on inflammatory diets exhibited a significantly higher odds ratio (OR) for experiencing more severe steatosis (OR: 4.11; 95% CI: 1.08–15.71) compared to those on anti-inflammatory diets. Furthermore, each unit increase in DII scores was linked to a 2.6-fold increase in the odds of more severe steatosis (OR: 2.61; 95% CI: 1.28–5.32) and a 0.006 increase in FIB-4 scores (β: 0.006; 95% CI: 0.003–0.011). In conclusion, modifying dietary intakes to lower DII scores may be a beneficial approach to improving clinical outcomes in pediatric MASLD, as anti-inflammatory diets are associated with reduced severity of hepatic steatosis and fibrosis.
ISSN:2045-2322

Similar Items